Reliability and Reproducibility of Automated Angular Measurement in Strabismus
FREGMA
1 other identifier
observational
73
1 country
1
Brief Summary
Angular measurement of deviation is an essential element in the clinical evaluation of strabic patients. It is performed by orthoptic methods. However, studies show that the same patient presents a great variability of his angular measurement between 2 consultations, and between 2 observers. Automated angle measurement is a recent concept that aims to overcome the defects of subjective angle measurement by alternate occlusion test and prismatic bar. Improvements made by these devices would provide reliable, objective and reproducible measurements of the angle of deviation by increasing the accuracy of strabal angle assessment, improving decision making and surgical follow-up, decreasing inter-examiner variability and variability over time, and facilitating data comparison to improve scientific publication possibilities. The Gazelab® device is a video-oculograph combined with a laser projection system and an infrared camera. It allows an objective angular evaluation, in non-dissociating physiological conditions, possible even in the absence of binocular vision and allows an analysis of the deviation in all positions. There is extremely little data in the literature on automated measuring devices. The Gazelab tool is still little known in the strabology discipline and seems to have a number of advantages over other devices. The interest of this examination towards this pathology led the ophthalmology department to use it in the current practice, and since recently it is an act nomenclaturé.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 10, 2018
CompletedFirst Posted
Study publicly available on registry
July 23, 2018
CompletedStudy Start
First participant enrolled
September 4, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 29, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 29, 2019
CompletedNovember 25, 2022
November 1, 2022
8 months
July 10, 2018
November 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intra-class correlation coefficient
Intra-class correlation coefficient calculated on the 4 measures (2 of each technique) of each patient taken at time 1 by the same assessor.
12 months
Secondary Outcomes (2)
Intra-class correlation coefficient using measurements
12 months
Intraclass correlation coefficient using time 1 and time 2 measurements
12 months
Interventions
Compare the results of the Gazelab to the alternate occlusion by prism bar (standard gold) examiners.
Eligibility Criteria
Strabismus is a pathology that affects 2 to 4% of the French population. The Ophthalmology Department sees 200 adult patients with strabismus per month. In 6 months it will be easy to include in 30 months 30 patients of convergent strabismus and 30 of divergent strabismus. For patients with eye strain who do not have eye refractive errors the Department of Ophthalmology sees 2000 patients per month, to include these 30 patients in 6 months. Since this study is a prospective non-interventional research study, the patient may be part of a biomedical research study.
You may qualify if:
- Patients over 18 years of age
- Strabic convergent or divergent patients or patients requiring an oculomotor check-up in their follow-up consultation
- Patient giving oral consent to this study
You may not qualify if:
- Patient with medical follow-up impossible,
- Impossibility to install Gazelab equipment for anatomical reasons of the head (craniostenosis...)
- No ocular fixation.
- Major without freedom under guardianship or trusteeship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Nantes
Nantes, 44000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pierre LEBRANCHU, Dr
Nantes University Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 10, 2018
First Posted
July 23, 2018
Study Start
September 4, 2018
Primary Completion
April 29, 2019
Study Completion
April 29, 2019
Last Updated
November 25, 2022
Record last verified: 2022-11